10.93

0.32% -0.045

Beta Bionics Inc (BBNX)

Overview News Price History Discussions Forecast

Beta Bionics Inc stock is traded at $10.93, with a volume of 169.96K. It is down -0.32% in the last 24 hours and down -22.56% over the past month. Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Previous Close:

$10.97

Open:

$10.88

24h Volume:

169.96K

Relative Volume:

0.14

Market Cap:

$483.77M

Revenue:

$78.02M

Net Income/Loss:

$-73.37M

P/E Ratio:

-6.5053

EPS:

-1.6794

Net Cash Flow:

$-62.06M

1W Performance:

-3.91%

1M Performance:

-22.56%

6M Performance:

-56.85%

1Y Performance:

-27.20%

1-Day Range:

$10.70

$11.27

1-Week Range:

$10.05

$11.30

52-Week Range:

$8.89

$32.71

Beta Bionics Inc Stock (BBNX) Company Profile

Name

Beta Bionics Inc

Sector

Healthcare (1117)

Industry

Medical Devices (139)

Phone

949-427-7785

Address

11 HUGHES, IRVINE

Employee

423

Twitter

Next Earnings Date

2025-03-25

Latest SEC Filings

BBNX's Discussions on Twitter

Compare BBNX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BBNX Beta Bionics Inc	10.90	486.87M	78.02M	-73.37M	-62.06M	-1.6794
ABT Abbott Laboratories	110.09	192.10B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	342.26	137.25B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	88.89	115.41B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	68.85	103.81B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	84.50	49.82B	6.07B	1.06B	1.34B	1.8063

Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Initiated	UBS	Buy
Jan-27-26	Initiated	TD Cowen	Hold
Jan-09-26	Downgrade	BofA Securities	Buy → Neutral
Oct-21-25	Resumed	Stifel	Buy
Oct-01-25	Upgrade	Goldman	Neutral → Buy
Jun-16-25	Initiated	Truist	Buy
Jun-12-25	Initiated	Lake Street	Buy
May-30-25	Initiated	Goldman	Neutral
May-30-25	Initiated	Wolfe Research	Outperform
Feb-24-25	Initiated	BofA Securities	Buy
Feb-24-25	Initiated	Lake Street	Buy
Feb-24-25	Initiated	Leerink Partners	Outperform
Feb-24-25	Initiated	Piper Sandler	Overweight
Feb-24-25	Initiated	Stifel	Buy
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral
Feb-20-25	Initiated	Robert W. Baird	Neutral

View All

Beta Bionics Inc Stock (BBNX) Latest News

Mar 10, 2026

Beta Bionics Earnings Call Signals Growth and Investment - TipRanks

Mar 10, 2026

Mar 09, 2026

INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - TMX Newsfile

Mar 09, 2026

Mar 07, 2026

Will Beta Bionics Inc. stock deliver consistent dividends2025 Historical Comparison & Free Fast Entry Momentum Trade Alerts - Naître et grandir

Mar 07, 2026

Trade Recap: Why is Beta Bionics Inc stock going downWeekly Market Report & High Yield Equity Trading Tips - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics - Bluefield Daily Telegraph

Mar 06, 2026

Beta Bionics Details iLet Automation Strategy, Sales Expansion and Mint Patch Pump Timeline at Conference - Yahoo Finance

Mar 06, 2026

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - Sahm

Mar 06, 2026

Beta Bionics, Inc. (NASDAQ:BBNX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Mar 06, 2026

Mar 05, 2026

Insider Sell: Mark Hopman Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus

Mar 05, 2026

Hopman, Beta Bionics CCO, sells $4k in BBNX stock By Investing.com - Investing.com Canada

Mar 05, 2026

Hopman, Beta Bionics CCO, sells $4k in BBNX stock - Investing.com UK

Mar 05, 2026